This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Aug 23;328(8):777-778.

doi: 10.1001/jama.2022.11232.

Pricing of Drugs With Evidence Development

Michael K Gusmano¹, David Chinitz², Victor Rodwin³

Affiliations

Affiliations

¹ College of Health, Lehigh University, Bethlehem, Pennsylvania.
² School of Public Health, Hebrew University and Hadassah in Jerusalem, Jerusalem, Israel.
³ Wagner School of Public Service, New York University, New York, New York.

PMID: 35997742
DOI: 10.1001/jama.2022.11232

Comment

Pricing of Drugs With Evidence Development

Michael K Gusmano et al. JAMA. 2022.

. 2022 Aug 23;328(8):777-778.

doi: 10.1001/jama.2022.11232.

Authors

Michael K Gusmano¹, David Chinitz², Victor Rodwin³

Affiliations

¹ College of Health, Lehigh University, Bethlehem, Pennsylvania.
² School of Public Health, Hebrew University and Hadassah in Jerusalem, Jerusalem, Israel.
³ Wagner School of Public Service, New York University, New York, New York.

PMID: 35997742
DOI: 10.1001/jama.2022.11232

No abstract available

PubMed Disclaimer

Comment in

Pricing of Drugs With Evidence Development-Reply.
Robinson JC. Robinson JC. JAMA. 2022 Aug 23;328(8):778. doi: 10.1001/jama.2022.11235. JAMA. 2022. PMID: 35997737 No abstract available.

Comment on

Drug Pricing With Evidence Development.
Robinson JC. Robinson JC. JAMA. 2022 Apr 26;327(16):1545-1546. doi: 10.1001/jama.2022.5403. JAMA. 2022. PMID: 35404379 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems